Descriptive statistics of dataset from the meta-analysis and meta-regression analysis on prognostic significance of pre-treatment systemic hemato-immunological indices of cervical cancer patients
Xingping Han(Affiliated Hospital of Southwest Medical University), Qiang Liu(Sun Yat-sen University), Qinglian Wen(Southwest Medical University), Hossein Hosseinifard(Hamedan University of Medical Sciences), Lisha Yang(National Clinical Research Center for Digestive Diseases), Saber İmani(Zhejiang Shuren University), Gang Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuya Liu(Universität Hamburg), Shaozhi Fu(Sichuan University), Mazaher Maghsoudloo(Islamic Azad University Medical Branch of Tehran)
Cited by 1
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Multiorgan and Renal Tropism of SARS-CoV-2
|New England Journal of Medicine|2020|1.9k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|434
An Ultrasound Activated Vesicle of Janus Au‐MnO Nanoparticles for Promoted Tumor Penetration and Sono‐Chemodynamic Therapy of Orthotopic Liver Cancer
|Angewandte Chemie International Edition|2019|338